Both in Pharmaceuticals
ABVC BioPharma vs Briacell Therapeutics
Over the past year ABVC returned −66.7% and BCTX returned −67.4%; their daily moves had a correlation of 0.12.
ABVC −66.7% BCTX −67.4%Growth of $1, one year, split-adjusted
| Metric | ABVC | BCTX |
|---|---|---|
| Price | $0.9850 | $3.26 |
| Market cap | $26.3M | $28.5M |
| Today | −0.01% | +8.31% |
| 1 month | +1.6% | −18.9% |
| 6 months | −10.4% | −21.4% |
| Year to date | −53.8% | −54.1% |
| 1 year | −66.7% | −67.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.9K | $20.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.6% | 77.8% |
| Short % of float | 2.7% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).